Publicaciones en colaboración con investigadores/as de University of California, San Diego (15)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

2022

  1. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

2021

  1. Serum acylcarnitines associated with high short-term mortality in patients with alcoholic hepatitis

    Biomolecules, Vol. 11, Núm. 2, pp. 1-14

2020

  1. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 1, pp. 87-101

  2. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  3. Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 21

  4. Imaging-AMARETTO: An imaging genomics software tool to interrogate multiomics networks for relevance to radiography and histopathology imaging biomarkers of clinical outcomes

    JCO Clinical Cancer Informatics, Vol. 4, pp. 421-435

  5. Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting

    Gut, Vol. 69, Núm. 4, pp. 764-780

2019

  1. Identification of resistance pathways specific to malignancy using organoid models of pancreatic cancer

    Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6742-6755

2018

  1. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis

    Journal of Hepatology, Vol. 69, Núm. 2, pp. 396-405

2013

  1. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 30, pp. 12391-12396

2012

  1. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness

    Cancer Research, Vol. 72, Núm. 1, pp. 365-374

2011

  1. Identifying polyglutamine protein species in situ that best predict neurodegeneration

    Nature Chemical Biology, Vol. 7, Núm. 12, pp. 925-934

2010

  1. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis

    Journal of Neuroscience, Vol. 30, Núm. 31, pp. 10541-10550

2000

  1. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis

    Molecular Endocrinology, Vol. 14, Núm. 6, pp. 848-862